The biggest institutional shareholders in Sangamo Therapeutics, Inc. include Wasatch Advisors Inc. which owns 7 million shares in the company valued at $60.99 million. As per Thursday, August 4, the company rating was downgraded by Janney Capital. Following the transaction, the vice president now owns 23,991 shares of the company's stock, valued at approximately $250,466.04. IL now owns 12,100 shares of the biopharmaceutical company's stock worth $106,000 after purchasing an additional 500 shares during the period.
A pretty useful way to understand how institutional investors view a certain stock's value is by taking a look at a public company's institutional holdings - especially current active positions.
Ecor1 Capital Llc holds 4.01% of its portfolio in Sangamo Therapeutics Inc for 2.57 million shares. Finally, Geode Capital Management LLC grew its holdings in shares of Sangamo Therapeutics by 3.1% in the 1st quarter. BlackRock Fund Advisors raised its position in Sangamo BioSciences by 5.7% in the third quarter. KAYNE ANDERSON CAPITAL ADVISORS LP had sold 17.25 million shares worth $668.96 million on Wednesday, May 24. Principal Financial Group Inc. increased its holdings in Sangamo Therapeutics by 6.8% in the second quarter. During last 3 month period, 0.66% of total institutional ownership has changed in the company shares.
Within those holders, 81 of them increased their positions - representing 14,460,939 shares of Sangamo Therapeutics, Inc. The company has market cap of $1.03 billion.
In other Sangamo Therapeutics news, Director William R. Ringo sold 31,000 shares of Sangamo Therapeutics stock in a transaction on Wednesday, September 20th.
Now insiders hold 1,841,586 shares in the business which makes up 2.21% of shares.
The most recent insider trade was by a Officer named HERBERTS CURT A. III, and it was an direct of 15000 shares - leaving the insider with 15833 shares after the transaction. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Last trading transaction put the stock price at $12.30. The disclosure for this sale can be found here.
This article was originally published by and is the sole property of American Banking News. If you are accessing this report on another website, it was illegally stolen and reposted in violation of United States & worldwide copyright and trademark laws.
Sangamo Therapeutics, Inc. has a beta of 4.02, offering the possibility of a higher rate of return, but also posing more risk. The company has a debt-to-equity ratio of 0.02, a quick ratio of 6.14 and a current ratio of 6.14. ValuEngine raised Sangamo Therapeutics from a "sell" rating to a "hold" rating in a research report on Friday, August 11th. Currently, 149.64 million total shares are owned by the public and among those 146.94 million shares have been available to trade. The firm had revenue of $8.30 million for the quarter, compared to analyst estimates of $5.82 million. Sangamo BioSciences had a negative net margin of 388.23% and a negative return on equity of 45.02%. Sangamo Therapeutics's quarterly revenue was up 124.3% on a year-over-year basis.
Shares of Sangamo Therapeutics (NASDAQ:SGMO) soared 2.93% or 0.35 to reach at $12.3 during previous trading session.
A number of research analysts have weighed in on the stock. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell. Piper Jaffray Companies set a $8.00 price objective on shares of Sangamo Therapeutics and gave the company a "hold" rating in a report on Thursday, August 10th. The stock of Sangamo Therapeutics Inc (NASDAQ:SGMO) earned "Overweight" rating by JP Morgan on Saturday, August 8. The stock of Sangamo Therapeutics Inc (NASDAQ:SGMO) has "Buy" rating given on Friday, October 13 by Jefferies.
Among 9 analysts covering Sangamo Biosciences (NASDAQ:SGMO), 4 have Buy rating, 1 Sell and 4 Hold. The stock has an average rating of "Hold" and an average price target of $14.40. Sangamo Therapeutics, Inc. has 83.61 million shares outstanding, and in the last trade has seen ATR around 0.8. The Company is focused on research, development and commercialization of engineered deoxyribonucleic acid (DNA)-binding proteins for therapeutic genome editing and gene regulation.
Melania Trump, joined by K-Pop singer Minho, greet South Korean students during "Girls Play 2" campaign event. However, the girls quickly become giddy with excitement when they notice Minho standing to their left.
More school bus makers simply need to get behind the technology in order to mass produce it and reduce the cost. Now they are leveraging their experience with those projects to unveil their first all-electric school bus .
From there, Brooks explains to his regular game night gang that this week, they're not playing any of the usual games. I'm not so sure how I feel about this movie directed by John Francis Daley and Jonathan Goldstein ( Vacation ).
With the existing current ratio, Lockheed Martin Corporation is more than equipped to confront its liabilities with its assets. Following the sale, the insider now directly owns 27,728 shares of the company's stock, valued at approximately $8,538,837.60.
Quantitative Invest Lc, a Virginia-based fund reported 53,200 shares. 236,725 were reported by King Luther Mngmt. (NASDAQ: BLDR ). SG Americas Securities LLC acquired a new stake in Builders FirstSource during the second quarter worth approximately $114,000.
Cowen and Company reaffirmed a hold rating on shares of United Parcel Service in a research report on Wednesday, July 19th. Jupiter Asset Management Ltd sold 189,600 shares as the company's stock declined 8.64% while stock markets rallied.
Following the purchase, the president now directly owns 188,995 shares of the company's stock, valued at $9,100,109.25. This repurchase authorization permits the company to buy up to 1.3% of its shares through open market purchases.
The Burgundy Asset Management Ltd holds 4.50 million shares with $179.23 million value, up from 3.20 million last quarter. The firm has "Hold" rating given on Monday, October 16 by BMO Capital Markets. 36,680 Maxim Integrated Products Inc .
Anka allegedly told the group what had happened, causing Bateman and his colleagues to become "visibly upset", the Times reports. Bateman's co-star Charlie Day and his wife Mary Elizabeth Ellis also told the Times they witnessed Balazs grope Anka.
In the most updated research from a number of analysts on Wall Street, the company gets 8 Buys and 0 Sell among 10 analysts. Comparatively, ACADIA Pharmaceuticals Inc . posted earnings of $-0.44 per share in the same quarter a year ago .
The firm has a market capitalization of $5,470.00, a price-to-earnings ratio of 15.46, a P/E/G ratio of 1.80 and a beta of 0.19. Nelson Van Denburg & Campbell Wealth Mngmt Gru Ltd Liability owns 1,404 shares or 0.05% of their United States portfolio.
Currently, 519.63 million total shares are owned by the public and among those 500.65 million shares have been available to trade. In the most updated research from a number of analysts on Wall Street, the company gets 10 Buys and 0 Sell among 20 analysts.
Procter & Gamble Company (The) (PG) Downgraded by Vetr Inc
Finally, RB Capital Management LLC increased its holdings in shares of Procter & Gamble Company (The) by 0.3% in the 1st quarter. It turned negative, as 51 investors sold WY shares while 269 reduced holdings. 7 funds opened positions while 21 raised stakes.
Original Faith No More Singer Chuck Mosley Dies at 57
Although his work with Faith No More was seen as a mix of genres, Mosley told Fear And Loathing he didn't see it that way. But Mosley was sacked from the group in 1988 before they released their third album. "Details to follow when arranged".
Supreme Court refuses to ban 'Padmavati' release
The Rajasthan government had earlier formed a panel to watch the Deepika Padukone-Shahid Kapoor-Ranveer Singh starrer. Meanwhile, Allahabad High Court's Lucknow bench has also dismissed a petition seeking stay on release of Padmavati .
Dollar Tree, Inc. (DLTR) Analysts See $0.89 EPS
Zacks Investment Research raised Dollar Tree from a "sell" rating to a "hold" rating in a research note on Thursday, July 27th. In other Tree.com news, CFO Gabriel Dalporto sold 8,425 shares of the firm's stock in a transaction on Friday, November 18th.
General Mills, Inc. (GIS) Upgraded to Hold at Societe Generale
Burke Herbert Bank & Trust Tru invested 1.98% in Pfizer Inc. (NYSE:PFE) for 78,608 shares. (NYSE:PFE) for 6.99 million shares. It increased, as 34 investors sold EXEL shares while 64 reduced holdings. 112 funds opened positions while 612 raised stakes.
Jharkhand: Fatwa issued against muslim woman for teaching yoga
Shia cleric Maulana Saif Abbas had said while referring to the fatwa issued against Naaz. "Protesting this is highly condemnable". Talking to a news agency, Naaz said,"I have received a lot of threats, I am thankful to the State Govt for providing security".
Technical Chart Situation for Humana Inc. (HUM)
Currently, 474.34 million total shares are owned by the public and among those 401.33 million shares have been available to trade. Mason Street Advsr Limited Liability Com has 0.07% invested in Graco Inc. (NYSE:ICB). 575,022 were accumulated by Sit Inv Assocs.
SpaceX wins Turksat pair of launches
The agreements cover a "build and launch" contract already in place between Airbus and Turksat. Aerospace giant Airbus is building the two satellites, which will launch in 2020 and 2021.
Worth Watching Stock Hertz Global Holdings, Inc. (HTZ)
Analysts on average had expected a profit of $1.35 per share and revenue of $2.55 billion, according to Thomson Reuters I/B/E/S. Analyst rating score as published on FINVIZ are rated on a 1 to 5 scale. (NYSE: HTZ ) received a Buy rating from 0 analysts.
Zoetis Inc. (ZTS) Raised to Buy at BidaskClub
The company reported $0.65 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.63 by $0.02. It increased, as 90 investors sold CSCO shares while 594 reduced holdings. 153 funds opened positions while 670 raised stakes.